Current Studies

Meningococcus Vaccine Study

Find out more about this study

Please fill out the form below and we will be in touch shortly.

Participants needed: Age: 28-40

  Are you protected against 4 types of Meningococcal Disease?

About Meningococcus

  • Meningococcus is a family of germs (bacteria) that can cause meningitis, which is an infection of the surface of the brain.
  • Meningitis is rare, but it can be life-threatening or lead to permanent disability.
  • Common groups of meningococcus that can cause disease are A, C, W and

Am I eligible to participate?

  • Men and women, ages 28 to 40 years, in good health, who have not previously received a meningococcal vaccine.

What is the purpose of the study?

  • The meningococcus vaccine that is currently used, comes in two vials: one is a liquid, and the other vial has a separate part  that comes as a solid pellet. The doctor or nurse has to mix the two vials before giving it to you. This takes time during the visits and also requires more storage space
  • GSK has developed a new version of the vaccine that is one vial containing all four parts as a liquid. It takes less time to prepare and less space to store it.
  • This study will test to see if the new liquid injection vaccine is as safe and works as well as the current vaccine.

Participant commitment

  • Two visits over a six-month period. There are two blood draws, one vaccination, and three follow-up phone calls.
  • Participants will receive either a licensed or investigational Men ACWY Vaccine.

You will receive:

  • Reimbursement for your out of pocket expenses related to the study such as travel and parking.

Contact Jill Mutch

Phone (902) 470-3860

Email jill.mutch@iwk.nshealth.ca

Find out more about this study

Please fill out the form below and we will be in touch shortly.